Demo Data from VLDB 2026 / reviewers in the wild / expert
Jennifer T. Fouquier
dblp:261/3969
· DBLP profile ↗
2ranked-venue papers
1as first author
1since 2021 · last 2026
0000-0002-0975-8235ORCID · verified
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 2 · 1 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
2 papers |
Bioinformatics and computational biology · 100% |
Topics — the 5 heaviest of 6, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › computational microbiology
microbiome analysis |
1.0 | 1 | 2026 | EXPLANA: a user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studies · Bioinform. 2026 |
Bioinformatics and computational biology
biomedical text mining |
0.4 | 1 | 2020 | Applying citizen science to gene, drug and disease relationship extraction from biomedical abstracts · Bioinform. 2020 |
Bioinformatics and computational biology › biomedical text mining
relation extraction |
0.4 | 1 | 2020 | Applying citizen science to gene, drug and disease relationship extraction from biomedical abstracts · Bioinform. 2020 |
Bioinformatics and computational biology
biocuration |
0.1 | 1 | 2020 | Applying citizen science to gene, drug and disease relationship extraction from biomedical abstracts · Bioinform. 2020 |
Bioinformatics and computational biology › biomedical text mining
named entity recognition |
0.1 | 1 | 2020 | Applying citizen science to gene, drug and disease relationship extraction from biomedical abstracts · Bioinform. 2020 |
Methods — techniques the papers use, named apart from their topics
mixed effects model · 1.0machine learning · 1.0change analysis · 1.0natural language processing · 0.4citizen science · 0.4
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2026 | EXPLANA: a user-friendly workflow for EXPLoratory ANAlysis and feature selection in cross-sectional and longitudinal microbiome studiesabstractMOTIVATION: Longitudinal microbiome studies (LMS) are increasingly common but have analytic challenges including nonindependent data requiring mixed-effects models. Furthermore, large amounts of data motivate exploratory analysis to identify factors related to outcome variables. Although change analysis (i.e. calculating feature changes between timepoints) can be powerful, how to best conduct these analyses is often unclear. For example, observational LMS measurements show natural fluctuations, so baseline might not be a reference of primary interest, whereas for interventional LMS, baseline is typically a key reference point, often indicating the start of treatment. RESULTS: To address these challenges, a feature selection workflow, called EXPLANA (EXPLoratory ANAlysis), was developed for LMS that supports numerical and categorical data, and also accommodates cross-sectional studies. Machine learning methods were combined with different types of change calculations and downstream interpretation methods to identify statistically meaningful variables and explain their relationship to outcomes. EXPLANA generates an interactive report that textually and graphically summarizes methods and results. EXPLANA had good performance on simulated longitudinal data, with a balanced accuracy score of 0.91 (range: 0.79-1.00, SD = 0.05), outperformed an existing tool, QIIME 2 feature-volatility (balanced accuracy: 0.95 versus 0.56) and identified novel order-dependent categorical feature changes (e.g. different effect for A_B versus B_A). EXPLANA is broadly applicable and simplifies analytics for identifying features related to outcomes of interest. AVAILABILITY AND IMPLEMENTATION: Software is available at https://github.com/JTFouquier/explana and https://zenodo.org/records/17478745 (10.5281/zenodo.17478744). Documentation and demos are available at www.explana.io. Jennifer T. Fouquier, Maggie Stanislawski, John O'Connor, Ashley Scadden, Catherine A. Lozupone |
Bioinform. | 1 |
| 2020 | Applying citizen science to gene, drug and disease relationship extraction from biomedical abstractsabstractMOTIVATION: Biomedical literature is growing at a rate that outpaces our ability to harness the knowledge contained therein. To mine valuable inferences from the large volume of literature, many researchers use information extraction algorithms to harvest information in biomedical texts. Information extraction is usually accomplished via a combination of manual expert curation and computational methods. Advances in computational methods usually depend on the time-consuming generation of gold standards by a limited number of expert curators. Citizen science is public participation in scientific research. We previously found that citizen scientists are willing and capable of performing named entity recognition of disease mentions in biomedical abstracts, but did not know if this was true with relationship extraction (RE). RESULTS: In this article, we introduce the Relationship Extraction Module of the web-based application Mark2Cure (M2C) and demonstrate that citizen scientists can perform RE. We confirm the importance of accurate named entity recognition on user performance of RE and identify design issues that impacted data quality. We find that the data generated by citizen scientists can be used to identify relationship types not currently available in the M2C Relationship Extraction Module. We compare the citizen science-generated data with algorithm-mined data and identify ways in which the two approaches may complement one another. We also discuss opportunities for future improvement of this system, as well as the potential synergies between citizen science, manual biocuration and natural language processing. AVAILABILITY AND IMPLEMENTATION: Mark2Cure platform: https://mark2cure.org; Mark2Cure source code: https://github.com/sulab/mark2cure; and data and analysis code for this article: https://github.com/gtsueng/M2C_rel_nb. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Ginger Tsueng, Max Nanis, Jennifer T. Fouquier, Michael Mayers, Benjamin M. Good, Andrew I. Su |
Bioinform. | 3 |